Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 15/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 13/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 13/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 13/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 13/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 13/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 13/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 13/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 13/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.35 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25819734 | 0.85 | POLB (0.34) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL17320678 | 0.81 | MAPK1 (0.41) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL25606926 | 0.76 | TP53 (0.36) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL25701589 | 0.73 | HDAC3 (0.44) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL20445539 | 0.73 | DPP4 (0.38) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL18376154 | 0.73 | DRD2 (0.39) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL17601989 | 0.72 | MAPK1 (0.44) | — | |
| SCHEMBL25819729 | 0.71 | KMT2A (0.33) | — | |
| SCHEMBL25708150 | 0.70 | HPGD (0.45) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL13469511 | 0.70 | SMPD1 (0.44) | HDAC1HDAC6HDAC3HDAC4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230220008-A1 | MULTIMERIC BICYCLIC PEPTIDE LIGANDS | BICYCLETX LIMITED (GB) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220008-A1 | MULTIMERIC BICYCLIC PEPTIDE LIGANDS | CD40, TNFSF11, TNFRSF9 | HDAC1 2328/4885HDAC6 766/4885HDAC3 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.